The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway

Figure 1

The docking pictures of the main chemical constituents of SMY with NLRP3. (a) Ophiopogonin D-NLRP3. (b) Schisandrol B-NLRP3. (c) Ginsenoside Rf-NLRP3. (d) Ophiopogonin D-amino acid residues. (e) Schisandrol B-amino acid residues. (f) Ginsenoside Rf-amino acid residues.

(a)

(b)

(c)

(d)

(e)

(f)